Lawrence P. Andrews

Interleukin-35 Limits Anti-Tumor Immunity

Meghan E. Turnis, Deepali V. Sawant, Andrea L. Szymczak-Workman et al. · Immunity · 2016 · 309 citations · Full text

Life Sciences, Immunology, Oncology +17

LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity

Lawrence P. Andrews, Samuel C. Butler, Jian Cui et al. · Cell · 2024 · 235 citations · Full text

Life Sciences, Cancer Biology, Immunology +17

Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy

Lawrence P. Andrews, Anthony R. Cillo, Lilit Karapetyan et al. · Clinical Cancer Research · 2022 · 122 citations · Full text

Life Sciences, Immunology, Oncology +17

The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer

Annette Hayden, James J. Douglas, Matthew Sommerlad et al. · Urologic Oncology Seminars and Original Investigations · 2014 · 91 citations

Medicine, Cancer Biology, Oncology +12

Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding

Lawrence P. Andrews, Ashwin Somasundaram, Jessica Moskovitz et al. · Science Immunology · 2020 · 85 citations · Full text

Life Sciences, Cell Biology, Oncology +16